Advertisement

Annals of Surgical Oncology

, Volume 6, Issue 1, pp 4–7 | Cite as

Chemoradiation for Localized Pancreatic Cancer: Another Perspective

  • Douglas B. Evans
  • James L. Abbruzzese
Editorial

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Evans DB, Lee JE, Pisters PWT. Pancreaticoduodenectomy (Whipple operation), and total pancreatectomy for cancer. In: Nyhus LM, Baker RJ, Fischer JF, eds. Mastery of surgery. 3rd ed. Boston: Little, Brown, 1997:1233–49.Google Scholar
  2. 2.
    Evans DB, Abbruzzese JL, Rich TA. Cancer of the pancreas. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997:1054–87.Google Scholar
  3. 3.
    Robinson E, Lee J, Pisters P, Evans D. Reoperative pancreaticoduodenectomy for periampullary carcinoma. Am J Surg 1996;172:432–7.Google Scholar
  4. 4.
    Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en-bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg 1996;223:154–62.Google Scholar
  5. 5.
    Leach SD, Lee JE, Charnsangavej C, et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 1998;85:611–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Fuhrman G, Charnsangavej C, Abbruzzese JL, et al. Thin-section contrast enhanced computed tomography accurately predicts resectability of malignant pancreatic neoplasms. Am J Surg 1994;167:104–11.Google Scholar
  7. 7.
    Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928–37.PubMedGoogle Scholar
  8. 8.
    Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg 1979;189:205–8.Google Scholar
  9. 9.
    Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403–13.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 1999

Authors and Affiliations

  • Douglas B. Evans
    • 1
    • 2
  • James L. Abbruzzese
    • 1
  1. 1.Departments of Surgical Oncology and Gastrointestinal, Oncology and Digestive DiseasesThe University of Texas M. D. Anderson Cancer CenterHouston
  2. 2.Dept. of Surgical, Oncology-106The M. D. Anderson Cancer CenterHouston

Personalised recommendations